1Fischer A. Human primary immunodeficiency diseases: A perspective[J ]. Natl Immunol, 2004,5 ( 1 ) : 23 - 30.
2Lee Wl, Torgerson TR, Schumacher M J, et al. Molecular analysis of a large cohort of patients with the hyperimmunoglobulin M (IgM) syndrome[J]. Blood, 2005,105(5) . 1881 - 1890.
3Fischer A. Primary immunodeficiency - an introduction[J ]. Cell Mol Immunol,2006,3(2) : 155.
4Lam DS, Lee TL, Chart KW, et al. Primary immunodeficiency in Hong Kong and the use of genetic analysis for diagnosis [ J ]. Hong Kong Med J, 2005,11 (2) : 90 - 96.
5Jiang LP,Chan KW,Fang P,et al. Genetic analysis of 19 cases of primary irnmunodeficiency in China's Mainland[J ]. Cell Mol Immunol,2006,3(2) : 156.
9Chan KW, Chen T,Jiang L, et al. Identification of Bruton tyrosine kinase mutations in 12 Chinese patients with X- linked agarmnaglobulinaemia by long PCR - direct sequencing [J ]. Int J Immunogenet, 2006,33 (3) : 205 - 209.
10Chan KW, Lee TL, Chung BH, et al. Identification of five novel WASP mutations in Chinese families with Wiskott - Aldrich syndrome[J]. Hum Mutat ,2002,20(2) : 151 - 152.
二级参考文献9
1[2]Fischer A. Human primary immunodeficiency diseases: a perspective[J]. Nat Immunol,2004,5:23.
3[4]Ochs HD,Smith CIE,Puck JM. Primary immunodeficency diseases[M]. Oxford University Press,New York,Oxford,1999:459.
4[5]Antoine C,Muller S,Cant S,et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies:report of the European experience 1968-99[J]. Lancet,2003,361:553.
5[6]Hacein-Bey-Abina S,Le Deist F,Carlier F,et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy[J]. N Engl J Med,2002,346:1185.
6[7]Hacein-Bey-Abina S,von Kalle C,Schmidt M,et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency[J]. N Eng1 J Med,2003,348:255.
7[8]Applying public health strategies to primary immunodeficiency diseases:a potential approach to genetic disorders. 2004,6.1st available at http://www.cdc.gov/genomics/info/conference/PIsynop.htm
8[9]Valiaho J,Vihinen M. Structure-function effects in primary immunodeficiencies[J]. Scand J Immunol,2000,52:22.
9[10]Gambineri E,Torgerson TR,Ochs HD. Immune dysregulation,polyendocrinopathy,enteropathy,and X-linked inheritance(IPEX). A syndrome of systemic autoimmunity caused by mutations of FOXP3,a critical regulator of T-cell homeostasis[J]. Curr Opin Rheumal,2003,15:430.
5Notarangelo L, Casanova JL, Conley ME, Chapel H, Puck J, Roifman C, et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005[J]. J Allergy Clin Immunol, 2006,117(4) :883-896.
6Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand [ J ]. J Clin Immunol, 2007, 27 ( 5 ) : 517-524.
7Shabestari MS, Maljaei SH, Baradaran R, Barzegar M, Hashemi F, Mesri A, et al. Distribution of primary immunodeficiency diseases in the Turk ethnic group, living in the northwestern iran[J].J Clin Immunol, 2007, 27 (5) :510-516.
8Boyle JM, Buekley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States [ J ]. J Clin Immunol, 2007, 27 ( 5 ) :497-502.
9Cooper MA, Pommering TL, Koranyi K. Primary immunodeficiencies [ J]. Am Faro Physician, 2003, 68 (10) :2001-2011.
10Owayed AF, Campbell DM, Wang EE. Underlying causes of recur- rent pneumonia in children[ J]. Arch Pediatr Adolesc Med, 2000, 154(2) :190-194.
